##gff-version 3
##sequence-region Q9HC78 1 741
Q9HC78	UniProtKB	Chain	1	741	.	.	.	ID=PRO_0000047733;Note=Zinc finger and BTB domain-containing protein 20	
Q9HC78	UniProtKB	Domain	104	167	.	.	.	Note=BTB;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00037	
Q9HC78	UniProtKB	Zinc finger	578	600	.	.	.	Note=C2H2-type 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9HC78	UniProtKB	Zinc finger	606	628	.	.	.	Note=C2H2-type 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9HC78	UniProtKB	Zinc finger	634	656	.	.	.	Note=C2H2-type 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9HC78	UniProtKB	Zinc finger	662	684	.	.	.	Note=C2H2-type 4;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9HC78	UniProtKB	Zinc finger	715	737	.	.	.	Note=C2H2-type 5;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9HC78	UniProtKB	Modified residue	211	211	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q9HC78	UniProtKB	Modified residue	353	353	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q9HC78	UniProtKB	Modified residue	357	357	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8K0L9	
Q9HC78	UniProtKB	Modified residue	690	690	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8K0L9	
Q9HC78	UniProtKB	Modified residue	695	695	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8K0L9	
Q9HC78	UniProtKB	Cross-link	330	330	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25114211;Dbxref=PMID:25114211	
Q9HC78	UniProtKB	Cross-link	330	330	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25114211,ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25114211,PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
Q9HC78	UniProtKB	Cross-link	371	371	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9HC78	UniProtKB	Cross-link	723	723	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9HC78	UniProtKB	Alternative sequence	1	73	.	.	.	ID=VSP_032503;Note=In isoform 2. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11230166,ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:17974005;Dbxref=PMID:11230166,PMID:15489334,PMID:17974005	
Q9HC78	UniProtKB	Natural variant	590	590	.	.	.	ID=VAR_072583;Note=In PRIMS%3B does not affect subcellular location%3B strongly reduced DNA binding%3B reduced ability to repress transcription%3B dominant-negative effect of the mutant on the wild-type allele. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25017102;Dbxref=dbSNP:rs483353064,PMID:25017102	
Q9HC78	UniProtKB	Natural variant	596	596	.	.	.	ID=VAR_072584;Note=In PRIMS%3B strongly reduced DNA binding%3B strongly reduced ability to repress transcription%3B dominant-negative effect of the mutant on the wild-type allele. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25017102;Dbxref=dbSNP:rs483353066,PMID:25017102	
Q9HC78	UniProtKB	Natural variant	602	602	.	.	.	ID=VAR_072585;Note=In PRIMS%3B strongly reduced DNA binding%3B strongly reduced ability to repress transcription%3B dominant-negative effect of the mutant on the wild-type allele. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25017102;Dbxref=dbSNP:rs483353068,PMID:25017102	
Q9HC78	UniProtKB	Natural variant	621	621	.	.	.	ID=VAR_072586;Note=In PRIMS%3B strongly reduced DNA binding%3B reduced ability to repress transcription%3B dominant-negative effect of the mutant on the wild-type allele. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25017102;Dbxref=dbSNP:rs483353070,PMID:25017102	
Q9HC78	UniProtKB	Sequence conflict	224	224	.	.	.	Note=S->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HC78	UniProtKB	Sequence conflict	266	266	.	.	.	Note=V->M;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HC78	UniProtKB	Sequence conflict	332	332	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HC78	UniProtKB	Sequence conflict	337	337	.	.	.	Note=Y->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HC78	UniProtKB	Sequence conflict	465	465	.	.	.	Note=S->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HC78	UniProtKB	Sequence conflict	517	517	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HC78	UniProtKB	Sequence conflict	543	543	.	.	.	Note=S->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
